Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)

About the company

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

4

$NoneM

Total Revenue

4

Employees

$14.80M

Market Capitalization

-1.95

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 391056.16 82729.00 6.28 22.79 20.75
Merck & Co., Inc. MRK 196889.19 48081.00 7.39 19.43 21.10
Pfizer Inc. PFE 190835.04 50660.00 2.89 12.08 31.17
Eli Lilly & Co. LLY 149964.48 23087.00 50.89 26.43 23.97
AbbVie, Inc. ABBV 143695.72 34057.00 -23.00 17.14 24.65
Bristol Myers Squibb Co. BMY 107221.81 31006.00 2.60 91.16 3.08
Repligen Corp. RGEN 6432.63 286.00 6.17 280.29 8.11
Reata Pharmaceuticals, Inc. RETA 4786.40 20.00 22.67 -15.39 -150.30
Nektar Therapeutics NKTR 4229.28 137.00 3.30 -9.21 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3862.82 1.00 35.71 -5.91 None
Allakos, Inc. ALLK 3213.86 None 6.98 -34.36 None
Karuna Therapeutics, Inc. KRTX 2505.88 None 6.54 -61.78 None
OPKO Health, Inc. OPK 2448.18 891.00 1.74 -8.37 -32.92
ADC Therapeutics SA ADCT 2343.60 2.00 27.64 -20.09 None
IGM Biosciences, Inc. IGMS 2191.70 None 9.66 -40.40 None
Turning Point Therapeutics, Inc. TPTX 2173.68 None 6.54 -18.19 None
Apellis Pharmaceuticals, Inc. APLS 2141.70 None 9.46 -5.13 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Principia Biopharma, Inc. PRNB 1792.84 30.00 6.38 -25.51 -242.01
Springworks Therapeutics, Inc. SWTX 1651.20 None 5.36 -26.48 None
Y-mAbs Therapeutics, Inc. YMAB 1477.04 None 9.05 -16.03 None
Zymeworks, Inc. ZYME 1393.98 26.00 2.89 -8.22 -629.37
Tricida, Inc. TCDA 1300.46 None 6.69 -6.16 None
Akcea Therapeutics, Inc. AKCA 1261.97 341.00 2.59 -44.86 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1223.75 None 6.34 -10.11 None
Odonate Therapeutics, Inc. ODT 1122.30 None 9.19 -9.97 None
Akero Therapeutics, Inc. AKRO 1092.43 None 9.12 -21.53 None
Arcutis Biotherapeutics, Inc. ARQT 1076.33 None 4.59 -17.21 None
Phibro Animal Health Corp. PAHC 1029.10 818.00 5.20 27.89 4.49
Athenex, Inc. ATNX 971.88 123.00 5.96 -9.03 -87.86
Constellation Pharmaceuticals, Inc. CNST 944.96 None 4.45 -10.18 None
Gossamer Bio, Inc. GOSS 792.39 None 3.22 -3.98 None
G1 Therapeutics, Inc. GTHX 774.63 1.00 3.35 -5.91 None
Quanterix Corp. QTRX 736.56 60.00 6.50 -16.84 -71.52
Phathom Pharmaceuticals, Inc. PHAT 731.00 None 4.06 -2.69 None
Krystal Biotech, Inc. KRYS 695.98 None 4.06 -33.56 None
Oric Pharmaceuticals, Inc. ORIC 691.88 None -7.51 -22.88 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Applied Therapeutics, Inc. APLT 642.22 14.00 4.15 -13.03 -19.41
Amneal Pharmaceuticals, Inc. AMRX 637.05 1679.00 4.39 -2.92 -11.85
Aprea Therapeutics, Inc. APRE 617.82 None 5.47 -18.27 None
Arcturus Therapeutics Holdings, Inc. ARCT 609.57 19.00 56.49 -21.91 -151.34
Keros Therapeutics, Inc. KROS 596.88 8.00 -26.96 -28.10 -285.35
Oyster Point Pharma, Inc. OYST 534.45 None 5.37 -9.29 None
Mirum Pharmaceuticals, Inc. MIRM 475.75 None 3.09 -7.02 None
Osmotica Pharmaceuticals Plc OSMT 473.58 232.00 3.59 -1.72 -115.44
SIGA Technologies, Inc. SIGA 467.40 19.00 5.23 -23.75 -94.00
89bio, Inc. ETNB 451.08 None 5.56 -6.99 None
Fulcrum Therapeutics, Inc. FULC 443.44 1.00 7.47 -6.43 None
Biospecifics Technologies Corp. BSTC 442.47 40.00 3.59 18.93 61.80
Satsuma Pharmaceuticals, Inc. STSA 437.75 None 4.31 -12.03 None
Imara, Inc. IMRA 424.15 None 4.10 -12.05 None
DURECT Corp. DRRX 390.60 28.00 30.00 -16.15 -82.94
Relmada Therapeutics, Inc. RLMD 380.97 0.00 5.68 -31.83 -877.66
TCR2 Therapeutics, Inc. TCRR 368.88 None 2.52 -36.60 None
Crinetics Pharmaceuticals, Inc. CRNX 366.96 1.00 4.63 -6.29 -447.78
Kala Pharmaceuticals, Inc. KALA 365.76 6.00 4.00 -3.98 None
Ocular Therapeutix, Inc. OCUL 356.16 6.00 -43.65 -3.88 None
Ovid Therapeutics, Inc. OVID 336.15 None 7.95 -5.15 None
Aeglea Biotherapeutics, Inc. AGLE 292.05 4.00 9.22 -3.64 -523.27
Gritstone Oncology, Inc. GRTS 291.24 4.00 2.61 -2.79 None
Urovant Sciences Ltd. UROV 281.70 None -4.99 -1.95 None
HOOKIPA Pharma, Inc. HOOK 268.32 13.00 2.43 -5.93 -333.02
IDEAYA Biosciences, Inc. IDYA 266.80 None 4.05 -6.12 None
Spero Therapeutics, Inc. SPRO 247.38 12.00 3.26 -3.04 -656.72
AMAG Pharmaceuticals, Inc. AMAG 246.84 321.00 0.94 -0.67 -115.05
Verrica Pharmaceuticals, Inc. VRCA 238.50 None 4.36 -7.82 None
KalVista Pharmaceuticals, Inc. KALV 221.58 12.00 2.45 -6.84 -263.38
Lannett Co., Inc. LCI 218.12 542.00 0.75 -7.17 -5.77
Sutro Biopharma, Inc. STRO 207.46 41.00 3.94 -3.40 -148.06
Kaleido Biosciences, Inc. KLDO 202.80 None 7.19 -2.77 None
Veru, Inc. VERU 198.90 39.00 6.65 -20.40 -25.53
Galera Therapeutics, Inc. GRTX 179.50 None 3.36 -2.73 None
LogicBio Therapeutics, Inc. LOGC 177.79 1.00 5.37 -4.18 None
Protara Therapeutics, Inc. TARA 164.52 None 2.47 -10.67 None
Liquidia Technologies, Inc. LQDA 163.68 8.00 12.83 -3.32 -602.17
Avenue Therapeutics, Inc. ATXI 156.16 532.00 28.71 -10.73 26.69
Lyra Therapeutics, Inc. LYRA 150.84 1.00 -1.28 -9.04 -491.16
Cyclerion Therapeutics, Inc. CYCN 145.26 6.00 1.83 -1.40 None
scPharmaceuticals, Inc. SCPH 144.97 119.00 3.70 -4.62 -27.05
Tyme Technologies, Inc. TYME 140.30 None 8.13 -6.42 None
PhaseBio Pharmaceuticals, Inc. PHAS 137.17 2.00 2.54 -2.87 None
Evelo Biosciences, Inc. EVLO 134.40 None 4.94 -1.53 None
Harrow Health, Inc. HROW 130.26 51.00 8.35 -5.27 -47.54
Mustang Bio, Inc. MBIO 126.80 None 2.96 -2.58 None
Immunic, Inc. IMUX 122.70 None 3.61 -55.77 None
TFF Pharmaceuticals, Inc. TFFP 122.36 None 4.74 -3.16 None
Aquestive Therapeutics, Inc. AQST 120.12 49.00 -6.92 -1.71 -139.64
Ayala Pharmaceuticals, Inc. AYLA 120.00 3.00 -2.82 -5.81 -679.19
Corvus Pharmaceuticals, Inc. CRVS 118.90 None 1.91 -2.52 None
NeuBase Therapeutics, Inc. NBSE 116.06 None 48.76 -2.60 None
Trevi Therapeutics, Inc. TRVI 104.76 None 2.22 -3.57 None
Evolus, Inc. EOLS 96.00 45.00 1.72 -0.95 -217.51
Milestone Pharmaceuticals, Inc. MIST 92.25 None 0.91 -1.48 None
Eton Pharmaceuticals, Inc. ETON 90.90 1.00 9.90 -4.55 None
EyePoint Pharmaceuticals, Inc. EYPT 81.75 26.00 5.77 -1.67 -196.30
Xeris Pharmaceuticals, Inc. XERS 72.24 4.00 3.58 -0.56 None
Clearside Biomedical, Inc. CLSD 71.34 6.00 9.16 -4.05 -293.61
Checkpoint Therapeutics, Inc. CKPT 70.80 2.00 6.10 -3.05 -949.53
Navidea Biopharmaceuticals, Inc. NAVB 68.85 1.00 -50.63 -6.23 -65.13
Baudax Bio, Inc. BXRX 63.54 None -1.73 -0.91 None
Genprex, Inc. GNPX 59.09 None 5.02 -4.32 None
BiomX, Inc. PHGE 58.74 None 1.55 -1.37 None
Aridis Pharmaceuticals, Inc. ARDS 58.50 1.00 -24.07 -2.00 -851.00
Assertio Therapeutics, Inc. ASRT 58.32 192.00 1.01 -0.36 -83.99
Aerpio Pharmaceuticals, Inc. ARPO 51.66 20.00 1.56 -2.74 -51.58
Menlo Therapeutics, Inc. MNLO 48.43 2.00 4.07 -0.52 -483.51
Edesa Biotech, Inc. EDSA 43.29 0.00 6.17 -0.46 -395.23
Eyenovia, Inc. EYEN 42.56 None 4.29 -2.08 None
Annovis Bio, Inc. ANVS 42.28 None 3.87 -33.56 None
Moleculin Biotech, Inc. MBRX 39.38 None 3.42 -4.28 None
Citius Pharmaceuticals, Inc. CTXR 36.18 None 2.68 -2.09 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Acer Therapeutics, Inc. ACER 35.00 3.00 2.55 -1.34 -274.69
AgeX Therapeutics, Inc. AGE 34.88 2.00 -45.90 -2.87 -658.11
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
Adamis Pharmaceuticals Corp. ADMP 33.64 22.00 1.29 -1.14 -140.33
Allena Pharmaceuticals, Inc. ALNA 32.20 None 4.24 -0.74 None
Aileron Therapeutics, Inc. ALRN 29.96 None 4.12 -1.13 None
CNS Pharmaceuticals, Inc. CNSP 29.92 None 5.19 -5.50 None
Oncternal Therapeutics, Inc. ONCT 28.99 3.00 3.72 -1.15 -225.89
Hoth Therapeutics, Inc. HOTH 25.80 None 7.17 -2.87 None
Millendo Therapeutics, Inc. MLND 25.43 0.00 0.60 -0.54 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Spring Bank Pharmaceuticals, Inc. SBPH 22.62 0.00 0.86 -0.87 None
Daré Bioscience, Inc. DARE 18.91 1.00 8.29 -1.13 None
ProPhase Labs, Inc. PRPH 18.36 9.00 1.66 -6.12 -31.15
Novan, Inc. NOVN 14.82 5.00 -3.41 -0.47 -602.34
Adial Pharmaceuticals, Inc. ADIL 14.80 None 3.61 -1.95 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
PDS Biotechnology Corp. PDSB 14.14 None 1.57 -0.55 None
Titan Pharmaceuticals, Inc. TTNP 11.60 4.00 4.83 -0.64 -437.91
Novus Therapeutics, Inc. NVUS 7.74 None 0.66 -0.37 None
Brickell Biotech, Inc. BBI 4.65 5.00 1.52 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD(TM) Pivotal Phase 3 Trial in Sweden and Estonia

7d ago, source: YAHOO!

CHARLOTTESVILLE, VA / ACCESSWIRE / July 6, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL:ADILW) ("Adial"), a clinical-stage biopharmaceutical company focused on the development of treatments for ...

ADial Pharmaceuticals Inc. Wt

7d ago, source: MarketWatch

03/29/2019 N/A S-1/A Registration Statement * 03/22/2019 N/A S-1 Registration Statement 02/19/2019 N/A S-1/A Registration Statement * 02/12/2019 N/A S-1 Registration Statement 08/16/2018 N/A S-8 ...

ADIL Adial Pharmaceuticals, Inc Common Stock

11d ago, source: Nasdaq

Based on 0 analysts offering recommendations for adil in the last 3 months.

2 Top Penny Stocks Get Up to 606% Profit Potential on Technology Catalysts

6d ago, source: Money Morning

And analysts say this penny stock is an opportunity for 264% gain in 12 months… Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is a pharmaceuticals company that specializes in developing treatments ...

Adial Pharma to launch late-stage ONWARD trial in Sweden and Estonia

7d ago, source: Seeking Alpha

Adial Pharmaceuticals (NASDAQ:ADIL) has received approvals in Sweden and Estonia to commence its landmark ONWARD pivotal Phase 3 clinical trial to investigate lead drug candidate, AD04, as a ...

Adial Pharmaceutical, Inc.: Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD Pivotal Phase 3 Trial in Sweden and Estonia

7d ago, source: Finanznachrichten

CHARLOTTESVILLE, VA / ACCESSWIRE / July 6, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL:ADILW) ("Adial"), a clinical-stage biopharmaceutical company focused on the development of treatments for add ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.